feed,title,long_url,short_url
Investors,Crispr Stock Slips; The FDA Could Approve The First CRISPR-Based Gene-Editing Drug In Just Six Months,https://www.investors.com/news/technology/crsp-stock-pops-as-fda-sets-december-date-to-potentially-ok-gene-editing-drug/,https://da.gd/YLuR
